Aktiesnakken — Januar 2012
-
Novozymes samarbetspartner inom enzymutveckling, amerikanska Poet, och det holländska bioteknikbolaget Royal DSM har ingått ett avtal om ett samriskbolag inom cellulosaetanol.
Det meddelade Poet och Royal DSM sent på måndagskvällen. Avtalet kan ha betydande negativa effekter på Novozymes potential i andra generationens biodrivmedel för enzymer i USA -
centa > du havde også vestas i 53 .. neeej centa .. jeg lytter når jeg ser du rammer 3 gange i træk ;-D
-
jeg håber at se FLS i de 360 .. jeg hoppede ud i 410 igår .. og vil da gerne ind i 360 .. men men men .. hvorfor skulle den dog komme derned... firmaet går jo godt .. rigtigt godt
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind